SEC Form D filing

Aeovian Pharmaceuticals, Inc., 2025-12-22

An SEC Form D private-offering notice from Berkeley, CA, a $54,999,996 filer-stated offering target in Biotech. Filed 2025-12-22. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Aeovian Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing a selective mTORC1 inhibitor for tuberous sclerosis complex related epilepsy

Filed 2025-12-22Filed to raise $54,999,996First money in 2025-11-18Raised so far $54,999,996HQ (as filed) Berkeley, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified aeovian.com↗Named in the filing 11 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source